Latest Leadership News

Chimeric Therapeutics has dosed the first three patients in its Phase 1/2 CHM CDH17 CAR-T trial targeting gastrointestinal cancers, alongside advancing its AML and NK cell therapy programs. The company also secured $5 million in funding and appointed Dr Rebecca McQualter as CEO.

Andromeda Metals has made significant strides in advancing its Great White Project, progressing funding efforts for Stage 1A+ and securing key operational milestones. The company also bolstered its leadership with new board appointments and received a substantial tax refund, positioning it for a critical investment decision.

Peninsula Energy has resumed uranium production at its flagship Lance Projects in Wyoming after a five-year pause, marking a pivotal step towards becoming a fully independent uranium producer. The company also announced key executive appointments and progress on plant construction despite some cost overruns and operational challenges.

Australian Pacific Coal has marked a significant milestone with the first commercial coal shipment from its Dartbrook mine, backed by a substantial financing boost and ongoing infrastructure upgrades.

Accelerate Resources has successfully raised $1.35 million to accelerate exploration at its newly acquired Kanowna East Gold Project, marking a strategic push into the prolific Kalgoorlie gold region.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Western Yilgarn NL reports encouraging exploration results at its Ida Holmes Project, alongside a successful capital raising and strategic board changes, setting the stage for accelerated development in 2025.

Aurora Energy Metals has executed a landmark Option Agreement with Eagle Energy Metals for its flagship Aurora Uranium Project, unlocking up to US$26 million in share consideration and retaining significant exposure through a 40% equity stake. The company also reports improved uranium recovery rates and strategic expansion into Western Australia.

Nova Eye Medical has completed a $6.6 million placement to fund growth initiatives, supported by strong global sales growth and a major shareholder commitment. The capital raise aims to bolster sales teams and product development as the company targets profitability in its glaucoma division.

McLaren Minerals has secured critical tenement transfers and completed a heritage survey, setting the stage for drilling at its McLaren Titanium Project in Western Australia. The company is progressing steadily towards a pre-feasibility study expected in Q2 2025.

4DS Memory Limited reports successful testing of its 60nm memory cells and progresses toward 20nm technology, alongside a $6 million capital raise and a new design partnership with Infineon.